Stake Acquisition of Lasergen, Inc.

Represented Lasergen, Inc., an emerging biotechnology company specializing in innovative next-generation sequencing technology, in an $80 million investment by Agilent Technologies Inc., a life sciences, diagnostics, and applied chemicals company, in exchange for a 48 percent stake in Lasergen.

Participating Lawyers

Sort By

Email Disclaimer